We develop technologies for site-specific drug delivery to the Central Nervous System, in particular the brain, for effective care of high-need patients.

Our Vision

The human brain has 100 billion neurons, each neuron connected to 10 thousand other neurons. Sitting on your shoulders is the most complicated object in the known universe.”  Michio Kaku

We overcome barriers by delivering therapies directly to the brain.

Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry and is based in Graz, Austria.

Technology Innovation

BIT Pharma technology is based on proprietary manufacturing process for tailored drug release at the site of action within the central nervous system (mainly the brain).

cGMP-compliant process

Development based on completely synthetic (no animal source), biodegradable, polymer system and hot melt extrusion process.

Intellectual Property

Preparations underway to broaden Intellectual Property base for additional applications.

Exclusive Manufacture

Possibility to secure exclusive manufacture of API and excipients for NicaPlant®.

Years of experience

The BIT Pharma Management Team embraces industry leading experience in non-clinical and clinical development, drug delivery technologies, as well as successful experience in general management.

Contact Us

Send us an email for further inquiry.

Not readable? Change text.